Aarti Industries Ltd.

NSE: AARTIIND | BSE: 524208 | ISIN: INE769A01020 | Industry: Specialty Chemicals
| Mid-range Performer
380.4000 -2.95 (-0.77%)
NSE Sep 25, 2025 15:31 PM
Volume: 313.9K
 

380.40
-0.77%
Reliance Securities
Revenue from pharma business grew by 3% YoY. Notably, the segment recorded its highest therapies i.e. antihypertensive, cardiovascular, oncology and corticosteroids etc. The company also has a strong pipeline of approvals and visibility to maintain growth momentum. Segmental EBIT grew by 20% YoY in 3QFY20, and we expect similar growth in 4QFY20E as well. Specialty Chemical Biz Slight Decline in Margin...
Aarti Industries Ltd. has lost -35.19% in the last 1 Year
More from Aarti Industries Ltd.
Recommended